Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Nexvet Biopharma plc (NVET)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
02/13/2018
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/10/2017
15-12B
Form 15-12B - Securities registration termination [Section 12(b)]:
08/08/2017
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/31/2017
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/31/2017
RW
Form RW - Registration Withdrawal Request:
07/31/2017
8-K
Quarterly results
07/31/2017
25-NSE
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/28/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 17(d) Announcement
07/10/2017
8-K
Form 8-K - Current report:
07/10/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 17(c) Announcement
07/05/2017
8-K
Form 8-K - Current report
07/05/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/05/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement
07/03/2017
GN
Nexvet Biopharma plc ("Nexvet") Supplement Announcement
06/30/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/19/2017
8-K
Form 8-K - Current report
06/19/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/19/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement
06/16/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/16/2017
8-K
Form 8-K - Current report
06/16/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/16/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 15 Announcement
06/14/2017
8-K
Form 8-K - Current report
06/14/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/14/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement
06/09/2017
CT ORDER
Form CT ORDER - Confidential treatment order
06/07/2017
8-K
Form 8-K - Current report
06/07/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/07/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 17(b) Announcement
06/05/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/02/2017
DEFM14A
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
06/02/2017
GN
Nexvet Biopharma plc ("Nexvet") Rule 17 Announcement
06/02/2017
8-K
Form 8-K - Current report
06/02/2017
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy